Search Within

Jaap Jan Boelens

  1. "Vanessa Fabrizio"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (1)
Groups
  1. Biostatistics Service (4)
  2. Epidemiology and Biostatistics (4)
  3. Pediatrics, Department of (4)
  4. Sloan Kettering Institute Postdocs (4)
  5. Stem Cell Transplantation and Cellular Therapy Service (4)
  6. Tow Center for Developmental Oncology (TCDO) (4)

More Groups

People
  1. Audrey Mauguen (4)
  2. Kevin Curran (4)
  3. Vanessa Fabrizio (4)
  4. Andromachi Scaradavou (3)
  5. Barbara Spitzer (3)
  6. Farid Boulad (3)

More People

Years
  1. 2021 (1)
  2. 2020 (1)
  3. 2019 (2)
Publications
  1. Blood (1)
  2. Bone Marrow Transplantation (1)
  3. Cytotherapy (1)
  4. Pediatric Blood and Cancer (1)
Publishers
  1. American Society of Hematology (1)
  2. Elsevier Science Ltd. (1)
  3. Nature Publishing Group (1)
  4. Wiley Periodicals, Inc (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Fludarabine-exposure predicts disease control following CD19-specific CAR T cell (tisagenlecleucel); A report from pediatric real-world CAR Consortium
    Meeting Abstract

    Curran, K. J.; Fabrizio, V. A.; Mauguen, A.; Boelens, J. J.; Baggott, C.; Prabhu, S.; Placenta, H.; Phillips, C. L.; Rossoff, J.; Stefanski, H.; more...
    Cytotherapy (2021)

    Fulltext@MSK | Save
  • Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant
    Journal Article

    Fabrizio, V. A.; Kernan, N. A.; Boulad, F.; Cancio, M.; Allen, J.; Higman, M.; Margossian, S. P.; Mauguen, A.; Prockop, S.; Scaradavou, A.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Allogeneic CD34-selected HSCT following CAR T-cells is associated with low TRM and favorable OS in pediatric/young adult patients with relapsed/refractory B-ALL
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M. I.; Higman, M. A.; Margossian, S. P.; Mauguen, A.; Prockop, S.; Scaradavou, A.; Shah, N. C.; Spitzer, B.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • CAR T-cells followed by CD34-selected T-cell depleted (TCD) ALLO-HSCT is associated with low toxicity and favorable overall survival
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M.; Margossian, S.; Mauguen, A.; Prockop, S.; Scaradavou, M.; Shah, N.; Spitzer, B.; Stieglitz, E.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save